ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AC27 | B | Selexipag - 200mcg | 10408 | 14620/1 | UPTRAVI | 200mcg | 60 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | 275,097,581 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AC27 | B | Selexipag - 200mcg | 10409 | 14720/1 | UPTRAVI | 200mcg | 140 | Tablet, film coated | Oral | Mersaco | Excella GmbH & Co KG | Germany | 613,462,617 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 12/12/20 | 0 |